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Various ocular disorders remain a major concern for 
medical care providers and health policy makers. Only in 
the US more than 6.6 million people were affected by 
blindness in 2011 (1). Meanwhile, even though people 
mostly inhabit low or moderate altitudes, about 140 
million people worldwide live above 2500 meters (2). 
Therefore, association between various vision disorders 
and high altitude remains a significant health concern for 
millions of people throughout the world. 
Residents of high-altitude areas are affected by reduced 
oxygen supply conditions. This, on one hand, results in 
higher levels of a hypoxia-inducible factor 1 (HIF-1), 
which increases expression of vascular endothelial grow 
factor (VEGF). In turn, this promotes pathological 
neovascularization and subsequent deterioration of such 
eye conditions as age-related macular degeneration 
(AMD) (3). On the other hand, high-altitude hypoxia 
triggers the release of erythropoietin (EPO), a general 
tissue-protective cytokine which was shown not only to 
protect neurons following retinal ischemia in vivo, but 
also to improve their recovery following injury (4). Other 
findings supported the hypothesis that EPO can be used 
to treat atrophic AMD (5). EPO administered systemically 
was shown to protect retinal ganglion cells somata from 
an optic nerve crash (6). 
EPO was also found to be effective in treating various 
sensorimotor disorders in a rat model of diffuse 
traumatic brain injury (TBI) and, very importantly, these 
beneficial effects occurred only under hypoxic conditions 
(7). Finally, EPO has a wide range of favorable effects in 
diabetic retinopathy, such as direct protection of retinal 
neuronal cells and the blood-retina barrier function (8). 
Those coupled with complex anti-inflammatory and anti-
oxidant effects exerted by EPO as well other beneficial 
properties described above could potentially impact the 
overall epidemiology of various ocular disorders as well 
as non-refractive vision impairment. 
Undoubtedly, further studies are needed to estimate the 
prevalence of various ocular disorders at different 
altitude levels. Currently, however, no population studies 
have examined this issue. Moreover, I hypothesize that 
not only the prevalence, but also prevention, treatment 
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and rehabilitation of various forms of vision and ocular 
disorders can be influenced, in part, by geographic 
altitude and the major mechanism is the excessive 
release of EPO in the high-altitude area. 
A special consideration should be placed on traumatic 
and war-related injuries (i.e. blast-related ocular trauma) 
that occur in the high-altitude level. Ocular injuries as 
well as trauma to other anatomical structures related to 
vision (i.e. optic nerve) are often viewed as accidental 
mechanical impact with prevalence that cannot be 
influenced by internal substances such as hormones (i.e. 
EPO). However, ocular and adjunct structures’ injury is 
complex entity with several pathophysiological events 
such as ischemia from vasospasm, apoptosis, 
inflammation, etc. An increased EPO production in the 
high-altitude is likely to affect many of these stages     
(i.e. cellular apoptosis). Therefore, not only the 
prevalence of ocular and optic injuries, but also various 
complications following trauma (i.e. vision impairment) 
are likely to be influenced by geographic altitude. 
Why is this important? Evidence that prevalence of 
important vision and ocular disorders, ocular injuries and 
their outcomes may vary at various altitude areas may 
open up new avenues for treatment, including 
emergency ocular trauma and optic nerve injury care. 
Such studies may help to identify various factors (i.e. age, 
gender, etc.) related to prevention, treatment and 
rehabilitation of patients diagnosed with a number of 
vision and ocular disorders at various altitudes. In 
addition, evidence that the prevalence of some vision 
and ocular disorders as well as ocular injury outcomes is 
lower in the high-altitude area would help to identify a 
new line of treatment with similar effect such as various 
EPO regimens, etc. Another research direction is to 
clarify the role of hyperbaric treatment as well as its 
possible complications in the prevention, treatment and 
rehabilitation of various vascular pathologies. It may also 
help to establish new research directions in this area as 
well as contribute to a better understanding of the 
pathophysiological mechanism of certain complex eye 
conditions (i.e. optic nerve injury, vision complications 
following TBI), which are currently not well understood. 
Since, on one hand, wartime theaters of operations have 
occurred in various parts of the Earth and very often 
much above the sea level and, on the other hand blast-
related ocular trauma is one of the most common 
injuries encountered by military combat today it may 
also help to improve the initial treatment of ocular 
trauma, optic nerve injury as well as vision and ocular 
disorders following TBI from the point of impact (i.e. 
blast) to the point of medical evacuation (9). 
Furthermore, there is a need to examine the relationship 
between various ocular pathology and both acute and 
chronic exposure to high-altitude. This is of particular 
importance since a short, more likely than a long-term 
hypoxia, has been hypothesized to promote the 
protection to neuronal cells (10). Finally, knowledge of 
geographic altitude increasing the risk of certain ocular 
conditions may help physicians and health policy makers 
to identify new at risk groups. 
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